FAQ

We are a professionally and operationally managed fund focused only on healthcare software and tech-enabled healthcare services start-ups. Our investors represent well known decision makers from providers, pharma, payers, and strategic healthcare partners. Once an investment is made – together, we roll up our sleeves and make it happen! We have a great relationship with many of the healthcare VCs, and we partner with them to syndicate deals.

EHV invests in healthcare software and tech-enabled healthcare services companies that enhance revenue and/or reduce healthcare costs while improving quality of care, workflow efficiency, and patient outcomes. We look for capital-efficient companies that we can add significant value and exit within a reasonable amount of time. We have a strong preference for start-ups with a B2B SaaS model.

We typically invest in late seed or early A start-ups, but remain opportunistic if we can add value elsewhere. We are generally part of the first professional money in the company. We take an active role in syndicating our deals with our investment partners to bring in additional capital and value. We tend to lead or co-lead our financing rounds.

EHV invests in passionate management teams that don’t have all the answers – a team that’s willing to be mentored and advised by experienced entrepreneurs to accelerate the growth of their company. We are focused only on healthcare SaaS and tech-enabled healthcare services with a B2B model.

Yes – ideally in a detailed presentation format. For the financials, please focus on a detailed cash-based forecast for the next 18-24 months.

There are great resources available on this topic; here is one:

Assuming the company has everything in order – in electronic format – it takes around 30-45 days. If this is your first time going through a due diligence process, do a search on “VC investment due diligence checklist.” The sooner you start organizing due diligence materials, the better. You will eventually need all of these materials in the future, especially as you get ready for an exit event.

Our decision-making process is a venture capital model in that the managing partners (with feedback from the advisory board and broader network) make the final investment decision. We have an agile process of looking at deals. Once we make a decision to invest, the investment is made directly from our committed healthcare funds.

You will be supported by the EHV team and its unique extended network of providers, pharma, payers, strategic partners, and contract resources.